Cargando…

Fecal microbiota transplantation can improve cognition in patients with cognitive decline and Clostridioides difficile infection

After fecal microbiota transplantation (FMT) to treat Clostridioides difficile infection (CDI), cognitive improvement is noticeable, suggesting an essential association between the gut microbiome and neural function. Although the gut microbiome has been associated with cognitive function, it remains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Soo-Hyun, Lee, Jung-Hwan, Kim, Jun-Seob, Kim, Tae Jung, Shin, Jongbeom, Im, Jae Hyoung, Cha, Boram, Lee, Suhjoon, Kwon, Kye Sook, Shin, Yong Woon, Ko, Sang-Bae, Choi, Seong Hye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467396/ https://www.ncbi.nlm.nih.gov/pubmed/35980280 http://dx.doi.org/10.18632/aging.204230

Ejemplares similares

Efficacy and Safety of Fecal Microbiota Transplantation for Clearance of Multidrug-Resistant Organisms under Multiple Comorbidities: A Prospective Comparative Trial
por: Shin, Jongbeom, et al.
Publicado: (2022)

Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with Clostridioides difficile Infection
por: Yoon, Hyuk, et al.
Publicado: (2021)

Prognosis of incompletely resected small rectal neuroendocrine tumor using endoscope without additional treatment
por: Cha, Boram, et al.
Publicado: (2022)

Efficacy of a novel hemostatic adhesive powder in patients with upper gastrointestinal tumor bleeding
por: Shin, Jongbeom, et al.
Publicado: (2021)

Fecal Microbiota of Toxigenic Clostridioides difficile-Associated Diarrhea
por: Hernández, Marta, et al.
Publicado: (2019)

Fecal microbiota transplantation beyond Clostridioides difficile infections
por: Wortelboer, Koen, et al.
Publicado: (2019)

Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection
por: Moon, Chang Mo, et al.
Publicado: (2021)

Characteristics of Faecal Microbiota in Korean Patients with Clostridioides difficile-associated Diarrhea
por: Jeon, Yong Duk, et al.
Publicado: (2019)

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection
por: Ahn, Seung Woo, et al.
Publicado: (2021)

2235. Fecal Biomarkers for Clostridioides difficile Infection in Cancer Patients
por: Olvera, Adilene, et al.
Publicado: (2019)

Usefulness of Fecal Calprotectin in the Management of Patients with Toxigenic Clostridioides difficile
por: Suarez-Carantoña, Cecilia, et al.
Publicado: (2021)

Fecal host biomarkers predicting severity of Clostridioides difficile infection
por: Golizeh, Makan, et al.
Publicado: (2021)

Fecal microbiota transplantation for recurrent Clostridioides difficile, safety, and pitfalls
por: Sandhu, Avnish, et al.
Publicado: (2021)

Exploration of Cognitive Outcomes and Risk Factors for Cognitive Decline Shared by Couples
por: Yang, Hee Won, et al.
Publicado: (2021)

Pragmatic Strategy for Fecal Specimen Storage and the Corresponding Test Methods for Clostridioides difficile Diagnosis
por: Nho, Seong Won, et al.
Publicado: (2021)

Refractory pseudomembranous colitis that was treated successfully with colonoscopic fecal microbial transplantation
por: Shin, Jun Young, et al.
Publicado: (2016)

Immunological mechanisms of fecal microbiota transplantation in recurrent Clostridioides difficile infection
por: Soveral, Lucas F, et al.
Publicado: (2022)

The value of fecal calprotectin in Clostridioides difficile infection: A systematic review
por: Wen, Bao-Jiang, et al.
Publicado: (2022)

Multiparity, Brain Atrophy, and Cognitive Decline
por: Jung, Joon Hyung, et al.
Publicado: (2020)

Fecal microbiota transplantation and donor screening for Clostridioides difficile infection during COVID-19 pandemic
por: Chiu, Cheng-Hsun, et al.
Publicado: (2021)

Investigation of Intestinal Microbiota and Fecal Calprotectin in Non-Toxigenic and Toxigenic Clostridioides difficile Colonization and Infection
por: Han, Sung-Hee, et al.
Publicado: (2020)

Interaction of Clostridioides difficile infection with frailty and cognition in the elderly: a narrative review
por: Fernandez-Cotarelo, Maria-Jose, et al.
Publicado: (2023)

Fecal Microbiota Transplantation for Clostridioides Difficile Infection in Patients with Chronic Liver Disease
por: Meighani, Alireza, et al.
Publicado: (2020)

Fecal Microbiota Transplantation Is Effective for the Treatment of Partially Treated Clostridioides difficile Infection
por: Cho, Young-Seok
Publicado: (2021)

Clinical Characteristics and Fecal Microbiome in Recurrent Versus Nonrecurrent Clostridioides difficile Infection
por: Lanjewar, Swapnil, et al.
Publicado: (2021)

Ischemic colitis complicated by Clostridioides difficile infection treated with fecal microbiota transplantation
por: Kang, Seok Hyung, et al.
Publicado: (2023)

Hospitalized Older Patients with Clostridioides difficile Infection Refractory to Conventional Antibiotic Therapy Benefit from Fecal Microbiota Transplant
por: Shin, Jae Hyun, et al.
Publicado: (2021)

A Case of Cerebral Amyloid Angiopathy Presented with Cognitive Decline and Hoarding Behavior
por: Lee, Jeewon, et al.
Publicado: (2020)

Simultaneous detection and ribotyping of Clostridioides difficile, and toxin gene detection directly on fecal samples
por: van Rossen, Tessel M., et al.
Publicado: (2021)

Faecalibacterium prausnitzii increases following fecal microbiota transplantation in recurrent Clostridioides difficile infection
por: Björkqvist, Olle, et al.
Publicado: (2021)

Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
por: Feuerstadt, Paul, et al.
Publicado: (2021)

Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
por: de la Villa, Sofía, et al.
Publicado: (2023)

The impact of the COVID-19 pandemic on Clostridioides difficile infection and utilization of fecal microbiota transplantation
por: Bachour, Salam P., et al.
Publicado: (2023)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

1211. Response to Fecal Microbiota Transplant (FMT) in Refractory Clostridioides difficile Infection (CDI) is Modest Compared to Recurrent CDI in Hospitalized Patients
por: Shin, Jae Hyun, et al.
Publicado: (2020)

Fecal microbiota transplantation is not a magical treatment, but better too early than too late
por: Shin, Jongbeom
Publicado: (2023)

Opportunities for Nanomedicine in Clostridioides difficile Infection
por: Wang, Pei-Wen, et al.
Publicado: (2021)

Fecal microbiota transplantation for treatment of refractory or recurrent Clostridioides difficile infection in Taiwan: a cost-effectiveness analysis
por: Lan, Kai-Yen, et al.
Publicado: (2023)

Hemostatic efficacy and safety of the hemostatic powder UI-EWD in patients with lower gastrointestinal bleeding
por: Cha, Boram, et al.
Publicado: (2022)

Nitro-Group-Containing Thiopeptide Derivatives as Promising Agents to Target Clostridioides difficile
por: Kim, Dahyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9bnl8np43tek9l57s6qhr8k918